"However, current methods to measure CCR5 RO lack sensitivity, resulting in high background and overcalculation. Here, we report on two independent, flow cytometric methods of calculating CCR5 RO using the anti-CCR5 antibody, Leronlimab."

Thanks Firelife619 for your post. I was wondering why more discussion of the paper didn't pop up immediately on the board yesterday. I have been attempting to formulate a similar post to yours. However, I couldn't have said it better.

To those that said Incelldx didn't fail RO, and that Cytodyn NEEDED Incelldx to Ev-Ar accomplish the HIV BLA RO requirement...

Take that (backhand bitch slap, followed by full on front slap)!

Thanks Fire,
Chazzle